Aspen Aerogels 過去の業績
過去 基準チェック /06
Aspen Aerogelsの収益は年間平均-44.3%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4% 25.4%割合で 増加しています。
主要情報
-44.28%
収益成長率
-19.21%
EPS成長率
| Chemicals 業界の成長 | 12.93% |
| 収益成長率 | 25.36% |
| 株主資本利益率 | -52.46% |
| ネット・マージン | -48.64% |
| 前回の決算情報 | 31 Mar 2026 |
最近の業績更新
Recent updates
ナラティブの更新 • Apr 30
ASPN: GM Demand Reset And Facility Disruption Will Pressure Shares
Analysts have cut Aspen Aerogels' price targets into a lower $3 to $6 range, citing Q4 and Q1 misses, GM related EV demand weakness, and a tough near term outlook, partially balanced by cost actions, a growing net cash position, and what they see as longer term platform value. Analyst Commentary Recent Street research highlights that several bearish analysts have reset expectations lower for Aspen Aerogels, trimming price targets into a $3 to $6 range after the Q4 earnings miss and a soft Q1 outlook.ナラティブの更新 • Apr 15
ASPN: GM Demand Reset And Tough Outlook Will Pressure Shares
Analysts have cut their average price targets on Aspen Aerogels to a range of about $3 to $6. This reflects weaker near term expectations tied to GM related EV softness, offset by company efforts to protect cash, reduce costs, and focus on longer term platform value.
ナラティブの更新 • Apr 01
ASPN: Cost Discipline And GM Settlement Cash Will Support Future Upside
Analysts have reduced their average price targets on Aspen Aerogels to a range of about $3 to $6, citing Q4 earnings and guidance shortfalls, ongoing softness tied to GM and the broader EV reset, as well as a sharper company focus on cash preservation and cost controls. Analyst Commentary Across recent research notes, analysts broadly cut price targets on Aspen Aerogels following Q4 results and softer guidance, but the tone is mixed rather than uniformly negative.ナラティブの更新 • Mar 18
ASPN: Cost Actions And Cash Support Will Drive Long-Term Upside Potential
Analysts have reduced the fair value estimate for Aspen Aerogels from $10 to $6, reflecting lower price targets across the Street as they weigh weaker GM related EV demand against the company's cost actions, cash support from the GM settlement, and longer term platform potential. Analyst Commentary Street research has shifted sharply lower on headline price targets, but the tone is not uniformly negative.ナラティブの更新 • Mar 04
ASPN: Tough Year And GM Demand Reset Will Pressure Shares
Narrative Update: Aspen Aerogels The analyst price target for Aspen Aerogels has moved from $6.00 to $3.00 as analysts factor in a tough year following a Q4 earnings miss and softer guidance, partly offset by cost actions and a stronger net cash position tied to the GM settlement. Analyst Commentary Bearish analysts have reset expectations for Aspen Aerogels, cutting price targets across the board after the Q4 earnings miss and softer near term guidance.Seeking Alpha • Feb 27
Aspen Aerogels: A Long Road Ahead
Summary Aspen Aerogels has experienced a dramatic boom-bust cycle, with shares plunging amid a dismal industry outlook and oversupply in EV insulation. After rapid revenue growth and a $2 billion expansion plan, Aspen halted new plant construction and saw revenues collapse from $453 million to a $300 million run rate. Guidance now points to Q4 sales of just $45 million and EBITDA losses of $10 million, highlighting severe operational and demand challenges. Despite a new European OEM contract and cost-cutting targets, Aspen faces long-term demand threats from solid-state battery developments and persistent market headwinds. Read the full article on Seeking Alphaナラティブの更新 • Feb 18
ASPN: Updated Profitability Assumptions Will Still Support Long-Term Upside Potential
Analysts have lifted their price target for Aspen Aerogels to $10.00, citing updated inputs around revenue growth, profit margins, and future P/E assumptions as the key drivers of this change. Valuation Changes Fair Value: revised slightly from $9.98 to $10.00 per share, aligning with the updated price target.
ナラティブの更新 • Feb 04
ASPN: Higher 2025 Loss Guidance Will Still Support Long-Term Opportunity
Analysts have adjusted their price target on Aspen Aerogels, highlighting a slightly higher discount rate and future P/E assumptions, along with modest tweaks to revenue growth and profit margin expectations, as they reassess the risk and earnings profile embedded in their valuation models. What's in the News Aspen Aerogels revised full year 2025 revenue guidance to a range of $270 million to $280 million, compared with prior guidance of $297 million to $317 million (company guidance).分析記事 • Jan 23
Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge Not Quite Adding Up
Those holding Aspen Aerogels, Inc. ( NYSE:ASPN ) shares would be relieved that the share price has rebounded 32% in the...ナラティブの更新 • Jan 20
ASPN: Lower 2025 Guidance Will Still Support Long-Term Upside Potential
Analysts have raised their price targets on Aspen Aerogels, citing updated assumptions for the discount rate, revenue growth, profit margin, and future P/E that together suggest a modest improvement in their overall outlook for the shares. What's in the News Aspen Aerogels revised its full-year 2025 revenue guidance to a range of US$270 million to US$280 million, compared with prior guidance of US$297 million to US$317 million (company guidance).ナラティブの更新 • Jan 06
ASPN: Lower 2025 Outlook Will Still Support Attractive Long-Term Upside Potential
Analysts have lifted their price target on Aspen Aerogels to reflect updated assumptions around revenue growth, profit margins, discount rate and future P/E. The new target implies a valuation aligned with these revised inputs compared with the prior figure.ナラティブの更新 • Dec 19
ASPN: Reduced Guidance And Higher Discount Rate Will Present Long-Term Upside Opportunity
Aspen Aerogels' consensus analyst price target has been reduced by approximately $4.02 per share, as analysts temper their assumptions for revenue growth and profit margins, while also applying a slightly higher discount rate and multiple to future earnings. What's in the News Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from prior expectations of $297 million to $317 million (Key Developments).ナラティブの更新 • Dec 05
ASPN: Improving Risk Profile Will Support Long-Term Opportunity Despite Wider Losses
Analysts have raised their price target on Aspen Aerogels by a modest amount, now embedding slightly lower discount rates and marginally softer future valuation multiples, as they emphasize the company’s improving risk profile and steady long term growth outlook. What's in the News Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from the prior outlook of $297 million to $317 million (company guidance).分析記事 • Dec 04
Aspen Aerogels (NYSE:ASPN) Might Have The Makings Of A Multi-Bagger
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...ナラティブの更新 • Nov 21
ASPN: Lower Profit Margins Will Drive Opportunity As Net Losses Peak
Analysts have lowered their price target for Aspen Aerogels from $8.75 to $6.83 per share. They cite revised expectations for slower revenue growth and profit margins.ナラティブの更新 • Nov 07
ASPN: Reduced EV Tax Credits Will Challenge Thermal Segment Performance Ahead
Analysts have lowered their price target for Aspen Aerogels from $9.58 to $8.75. They cited reduced electric vehicle production forecasts and increased macroeconomic pressures on the company’s key Thermal Barrier business segment.分析記事 • Oct 11
Optimistic Investors Push Aspen Aerogels, Inc. (NYSE:ASPN) Shares Up 27% But Growth Is Lacking
Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a really impressive month, gaining 27% after a shaky period...分析記事 • Aug 09
Aspen Aerogels, Inc. (NYSE:ASPN) Analysts Are Pretty Bullish On The Stock After Recent Results
NYSE:ASPN 1 Year Share Price vs Fair Value Explore Aspen Aerogels's Fair Values from the Community and select yours...ナラティブの更新 • Aug 08
Cost Optimization And Industrial Demand Will Shape Future Markets
The consensus price target for Aspen Aerogels has increased, reflecting a higher valuation multiple (future P/E rising from 14.46x to 20.08x) despite a notable decline in net profit margin (from 14.47% to 11.75%), resulting in a new fair value estimate of $9.75. What's in the News Ricardo Rodriguez will step down as CFO at the end of Q3 and be succeeded by Grant Thoele, who currently serves as Chief of Staff and VP of Corporate Strategy and Finance.分析記事 • Aug 06
Aspen Aerogels, Inc.'s (NYSE:ASPN) Shares Climb 28% But Its Business Is Yet to Catch Up
NYSE:ASPN 1 Year Share Price vs Fair Value Explore Aspen Aerogels's Fair Values from the Community and select yours...分析記事 • Jul 09
Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Jun 11
Aspen Aerogels, Inc.'s (NYSE:ASPN) 29% Share Price Surge Not Quite Adding Up
Those holding Aspen Aerogels, Inc. ( NYSE:ASPN ) shares would be relieved that the share price has rebounded 29% in the...分析記事 • Apr 17
Not Many Are Piling Into Aspen Aerogels, Inc. (NYSE:ASPN) Stock Yet As It Plummets 30%
To the annoyance of some shareholders, Aspen Aerogels, Inc. ( NYSE:ASPN ) shares are down a considerable 30% in the...分析記事 • Apr 01
Aspen Aerogels (NYSE:ASPN) Has A Pretty Healthy Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Seeking Alpha • Mar 31
Aspen Aerogels: Tariffs, Tesla And The Silver Lining
Summary Aspen Aerogels' growth is tied to the EV market, which faces uncertainty due to the potential elimination of the EV tax credit. Despite fears, Aspen Aerogels may benefit from Tesla's declining market share, as smaller EV players gain traction, particularly in Europe and China. US EV sales are expected to plateau until 2027, potentially limiting Aspen's revenue growth. But international markets offer expansion opportunities. The market may be overreacting to Aspen's stock decline. The company's prospects remain strong with increasing production capabilities in non-US markets. Read the full article on Seeking Alpha分析記事 • Feb 28
Positive Sentiment Still Eludes Aspen Aerogels, Inc. (NYSE:ASPN) Following 34% Share Price Slump
To the annoyance of some shareholders, Aspen Aerogels, Inc. ( NYSE:ASPN ) shares are down a considerable 34% in the...Seeking Alpha • Feb 14
Aspen Aerogels: Insulation Play Leaves Investors In The Cold
Summary Aspen Aerogels has seen significant revenue growth from EV insulation but faces challenges with EV demand, tariffs, and potential oversupply. Despite impressive revenue increases, shares have fallen due to concerns over market demand and halted construction of a new plant. The company reported strong 2024 sales and profits but faces a slowdown in EV revenue growth, with 2025 becoming a much tougher year. Given the uncertain outlook and recent setbacks, I remain cautious about ASPN stock but see the potential appeal if incremental improvements materialize throughout 2024. Read the full article on Seeking Alpha分析記事 • Feb 14
Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Seeking Alpha • Dec 23
Aspen Aerogels: There Are Reasons To Be Careful But It's So Cheap
Summary The company has recently taken on significant debt to finance its Statesboro plant. Stock were issued to improve the balance. The market didn't like but could make sense if it's compensated with growth thanks to the new Statesboro Plant. Q3 2024 earnings showed 92.93% YoY revenue growth and improved margins, but flat quarter-over-quarter sales led to a 28% stock decline. It's currently trading at 12 times forward EV/EBITDA and only 2.5 EV/Sales despite its revenue growth of almost 90%, so I think it's cheap. Read the full article on Seeking AlphaSeeking Alpha • Dec 02
Aspen Aerogels: Thermal Barriers Could Sustain Further Growth Despite A Chilly Market
Summary I find Aspen's 93% YoY revenue growth in Q3 2024 quite impressive, driven entirely by organic demand for PyroThin thermal barriers, with revenue guidance raised significantly this year. Gross margins climbed to 42% in the past quarter, while adj. EBITDA is projected to reach $90M in FY2024. Management's debt refinancing decision reduces dilution risks in the long term, a move I highly favor, despite the recent public offering. I foresee strong long-term growth from the Statesboro facility, set to generate $1.2–$1.6B annually, once completed in 2026. While potential changes to EV tax credits in the US and customer concentration pose risks, I believe Aspen's strong fundamentals and long-term growth drivers justify my cautious buy rating. Read the full article on Seeking AlphaSeeking Alpha • Nov 17
Aspen Aerogels: Despite Recent Pressure, This Is Intriguing
Summary Aspen Aerogels has transformed from an industrial insulation supplier to a key EV sector player, showing significant revenue growth and operating leverage. Despite impressive results and DOE funding news, shares fell due to a low-priced equity issue, concerns over EV demand, and uncertainty about a new factory. Shares dropped nearly 50% in a month, with third quarter sales up 93% YoY, driven by thermal barrier revenues, while facing capacity constraints. The company's valuation appears modest, with potential upside from the new factory and DOE loan, despite political and inflationary risks. Read the full article on Seeking Alpha分析記事 • Nov 07
With A 32% Price Drop For Aspen Aerogels, Inc. (NYSE:ASPN) You'll Still Get What You Pay For
Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a horrible month, losing 32% after a relatively good period...Seeking Alpha • Oct 28
Aspen Aerogels: Interesting Times
Summary Aspen Aerogels has transformed from an insulation supplier to a key player in the EV sector, showing strong revenue growth and operating leverage. Despite impressive quarterly results and preliminary DOE funding for a new plant, concerns about EV demand remain. The company raised $85 million through a share issuance, despite holding over $100 million in cash, raising questions about future funding needs. At around $20 per share, I see potential in Aspen Aerogels, despite recent share dilution and lack of sequential growth in Q3. Read the full article on Seeking Alpha分析記事 • Oct 17
Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Seeking Alpha • Sep 26
Aspen Aerogels: Current Valuation Is Not A Good Risk/Reward
Summary Aspen Aerogels' growth is constrained by its heavy reliance on General Motors, which may switch to superior battery technology, impacting ASPN's sales. The company's valuation appears overly optimistic, not adequately accounting for risks like EV market slowdown and uncertain DOE loan approval. Aspen Aerogels' Thermal Barrier division, crucial for growth, faces challenges that could slow down the company's overall progress and affect share prices. Current stock valuation at 3.7x book value lacks a sufficient margin of safety; a more attractive entry point would be at 2.5x P/B or $16.8 per share. Read the full article on Seeking AlphaSeeking Alpha • Sep 18
Aspen Aerogels: Management Guidance Remains Very Conservative
Summary Aspen Aerogel's unique aerogels offer unmatched thermal insulation, driving growth in legacy energy markets and the booming electric vehicle sector. The company's thermal barrier segment saw explosive growth, with a 98% increase year-over-year in 2023, leveraging its technology for EV battery protection. Aspen's gross margins expanded significantly by outsourcing energy industrial manufacturing, focusing on the high-demand thermal barrier business without needing new plant investments. Current management guidance is very conservative, but analyst expectations are based on this. Here's a Q3 beat opportunity and price reaction. Read the full article on Seeking Alpha
新しいナラティブ • Sep 11
Decisive Expansion And EV Innovations Propel Aerogel Giant Towards Financial Triumph
Expansion of production capacity and strategic financial management shows promise for significant revenue growth and improved net income through cost efficiency.分析記事 • Aug 24
Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge
Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a really impressive month, gaining 32% after a shaky period...分析記事 • Aug 15
Investors Shouldn't Be Too Comfortable With Aspen Aerogels' (NYSE:ASPN) Earnings
Aspen Aerogels, Inc. ( NYSE:ASPN ) just reported some strong earnings, and the market reacted accordingly with a...Seeking Alpha • Aug 12
Aspen Aerogels: Impressive, But Some Questions As Well
Summary Aspen Aerogels, Inc. has successfully transformed itself into a key supplier to the electric vehicle sector, with impressive sales growth and now earnings to show for. Momentum remains strong for the company, with significant capital spending questions arising as it aims to fulfill increasing demand. Despite concerns about the pace of the EV transition and delays in expansion plans, Aspen Aerogels shows strong operating performance and potential for growth. Read the full article on Seeking Alpha収支内訳
収支内訳
Aspen Aerogels の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 230 | -112 | 85 | 12 |
| 31 Dec 25 | 271 | -390 | 84 | 13 |
| 30 Sep 25 | 353 | -305 | 89 | 15 |
| 30 Jun 25 | 397 | -312 | 96 | 17 |
| 31 Mar 25 | 437 | -286 | 103 | 18 |
| 31 Dec 24 | 453 | 13 | 107 | 18 |
| 30 Sep 24 | 414 | 1 | 104 | 18 |
| 30 Jun 24 | 357 | 1 | 101 | 17 |
| 31 Mar 24 | 288 | -31 | 95 | 17 |
| 31 Dec 23 | 239 | -46 | 90 | 16 |
| 30 Sep 23 | 214 | -55 | 85 | 16 |
| 30 Jun 23 | 190 | -71 | 78 | 17 |
| 31 Mar 23 | 188 | -80 | 74 | 17 |
| 31 Dec 22 | 180 | -83 | 67 | 17 |
| 30 Sep 22 | 152 | -89 | 59 | 16 |
| 30 Jun 22 | 146 | -68 | 53 | 14 |
| 31 Mar 22 | 132 | -50 | 45 | 13 |
| 31 Dec 21 | 122 | -37 | 39 | 11 |
| 30 Sep 21 | 113 | -27 | 35 | 10 |
| 30 Jun 21 | 107 | -26 | 30 | 9 |
| 31 Mar 21 | 100 | -25 | 28 | 9 |
| 31 Dec 20 | 100 | -22 | 27 | 9 |
| 30 Sep 20 | 124 | -17 | 29 | 9 |
| 30 Jun 20 | 135 | -12 | 31 | 9 |
| 31 Mar 20 | 140 | -12 | 31 | 9 |
| 31 Dec 19 | 139 | -15 | 32 | 8 |
| 30 Sep 19 | 129 | -28 | 33 | 8 |
| 30 Jun 19 | 117 | -32 | 32 | 7 |
| 31 Mar 19 | 109 | -34 | 33 | 7 |
| 31 Dec 18 | 104 | -34 | 33 | 6 |
| 30 Sep 18 | 105 | -22 | 30 | 6 |
| 30 Jun 18 | 108 | -19 | 30 | 6 |
| 31 Mar 18 | 112 | -17 | 30 | 6 |
| 31 Dec 17 | 112 | -19 | 32 | 6 |
| 30 Sep 17 | 103 | -23 | 32 | 6 |
| 30 Jun 17 | 105 | -23 | 33 | 6 |
| 31 Mar 17 | 108 | -19 | 32 | 6 |
| 31 Dec 16 | 118 | -12 | 29 | 5 |
| 30 Sep 16 | 127 | -5 | 28 | 5 |
| 30 Jun 16 | 129 | -4 | 27 | 5 |
| 31 Mar 16 | 132 | -5 | 27 | 5 |
| 31 Dec 15 | 123 | -6 | 26 | 5 |
| 30 Sep 15 | 113 | -11 | 25 | 6 |
| 30 Jun 15 | 107 | -11 | 25 | 6 |
質の高い収益: ASPNは現在利益が出ていません。
利益率の向上: ASPNは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ASPNは利益が出ておらず、過去 5 年間で損失は年間44.3%の割合で増加しています。
成長の加速: ASPNの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: ASPNは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -1.4% ) と比較することは困難です。
株主資本利益率
高いROE: ASPNは現在利益が出ていないため、自己資本利益率 ( -52.46% ) はマイナスです。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/21 14:34 |
| 終値 | 2026/05/21 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Aspen Aerogels, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16
| アナリスト | 機関 |
|---|---|
| Benjamin Kallo | Baird |
| J. David Anderson | Barclays |
| J. David Anderson | Barclays |